Markntel Advisors’ report, Africa HIV Drugs Research Report: Trend, Business Growth, Size, Future Scope, Segmentation, Dynamics, and Forecast to 2030, offers a comprehensive guide for the growing industry. The expert team of analysts dedicated significant effort to gathering and evaluating the latest market data, resulting in a detailed and up-to-date report that offers valuable insights for individuals who rely on data-driven decisions, including business owners and analysts. The research report on the Africa HIV Drugs presents well-researched facts and figures pertinent to the industry, whether the goal is to explore new markets, launch a new product, or maintain a competitive advantage.
Africa HIV Drugs Market Industry Research Report & Market Summary:
The Africa HIV Drugs Market size is estimated to grow at a CAGR of around 8.20% during the forecast period, i.e., 2024-30. The market growth has been attributed to sustainable economic growth and poverty reduction efforts that contributed to improved access to healthcare services, including HIV treatment. Africa has a large and growing population, with a high prevalence of HIV/AIDS compared to other regions.
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/africa-hiv-drugs-market.html
Africa HIV Drugs Market Dynamics:
Key Driver-
The High Rate of HIV in African Girls & Women – The epidemiological evidence suggests that the prevalence and rates of HIV are unacceptably high among women in Africa. For instance,
- As per the Joint United Nations Programme, in 2022, adolescent girls and young women accounted for more than 77% of new infections among young people aged 15-24 years in sub-Saharan Africa.
- The UNAIDS data also highlighted that every week, 3100 adolescent girls and young women aged 15–24 years became infected with HIV in sub-Saharan Africa in 2022.
The combination of several factors, including biological, social, behavioral, cultural, economic, and structural, in sub-Saharan Africa has led to a disparate increase in HIV infection rates among women compared to their male counterparts. Thus, the rising HIV cases further necessitate that the young girls and women in the region go for proper diagnosis and treatment for HIV to avoid adverse consequences. This has been primarily because the treatment in the form of HIV drugs belonging to different classes, such as nucleoside reverse transcriptase inhibitors (NRTIs), integrase inhibitors, protease inhibitors, etc., not only allows these women with HIV to live longer, healthier lives but also reduces the risk of further HIV transmission.
Moreover, the rising awareness among African women regarding the effects of HIV drugs and their willingness to live longer and healthier lives would further augment the size & volume of the Africa HIV Drugs Market in the coming years.
Africa HIV Drugs Market Segmentation Analysis:
According to MarkNtel study the market is segmented into the following categories:
By Drug Class
- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)- Market Size & Forecast 2019-2030, USD Million
- Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)- Market Size & Forecast 2019-2030, USD Million
- Protease Inhibitors- Market Size & Forecast 2019-2030, USD Million
- Integrase Inhibitors- Market Size & Forecast 2019-2030, USD Million
- Fusion Inhibitors-Vector- Market Size & Forecast 2019-2030, USD Million
- Coreceptor Antagonists- Market Size & Forecast 2019-2030, USD Million
- Combination HIV Drugs- Market Size & Forecast 2019-2030, USD Million
- Others (Pharmacokinetic Enhancers, Capsid Inhibitors, etc.)- Market Size & Forecast 2019-2030, USD Million
NNRTIs have been observed to play a crucial role in first-line HIV treatment protocols as recommended by the World Health Organization (WHO).
By Route of Administration
- Oral Drugs- Market Size & Forecast 2019-2030, USD Million
- Injectable Drugs- Market Size & Forecast 2019-2030, USD Million
By Distribution Channel
- Hospital Pharmacies – Market Size & Forecast 2019-2030, USD Million
- Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
- Online Pharmacies- Market Size & Forecast 2019-2030, USD Million
The retail pharmacies segment accounted for the largest share of the Africa HIV Drugs Market. The presence of retail pharmacies across Africa helped improve access to HIV medications for individuals living with the virus by providing convenient points of distribution in urban and rural areas alike.
By Country
- South Africa
- Algeria
- Nigeria
- Kenya
- Uganda
- Rest of Africa.
Kenya experienced substantial growth in the Africa HIV Drugs Market owing to several factors. The country has made significant strides in expanding access to HIV treatment and care services through initiatives such as the Kenya AIDS Strategic Framework and the Kenya National AIDS Strategic Plan. These efforts have led to increased testing, earlier diagnosis, and improved treatment coverage, driving demand for HIV drugs.
North American region depicts considerable growth in the market, as the region captured the major share of the Africa HIV Drugs Market owing to a large patient pool, increasing per capita healthcare expenditure, and soaring investment, merger, and acquisition of key players across the region.
As indicated in the latest market research report published by Markntel Advisors, “Africa HIV Drugs Research Report: Forecast (2024-2030)”, this report offers a detailed analysis of the industry, featuring insights into the Africa HIV Drugs. It encompasses competitor and geographical analyses, as well as recent advancements in the market.
Browse Full Report Along with TOC and Figures – https://www.marknteladvisors.com/research-library/africa-hiv-drugs-market.html
Top Companies Operating in the Africa HIV Drugs Market:
- Aurobindo Pharma
- ViiV Healthcare group of companies
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Cipla Inc.
- Bristol-Myers Squibb Company
- AbbVie Inc.
- Gilead Sciences, Inc.
- Aspen Holdings
- Cosmos Limited
Note – If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*
Other Report:
- https://www.apsense.com/article/833859-2022-27-outlook-automotive-4d-imaging-radar-market-demand-top-companies.html
- https://www.apsense.com/article/833855-us-automotive-brake-pad-market-size-share-and-growth-projection.html
- https://www.apsense.com/article/833794-oman-air-conditioner-market-reaches-usd-495-million-in-2024.html
- https://www.apsense.com/article/833788-saudi-arabia-facility-management-market-expected-to-achieve-usd-33-38.html
- https://www.apsense.com/article/833551-brazil-off-the-road-otr-tire-market-steady-growth-with-a-cagr.html
Key Report Highlights:
- Market Dimensions & Projections
- Pricing Evaluation,
- Recent Strategic Moves by Companies,
- Primary Stakeholders,
- Analysis of Import and Export Trends,
- Competitive Landscape Assessment,
- Emerging Opportunities,
- Market Trends and Indicators
Frequently Asked Questions (FAQs)-
- What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
- What are the trends influencing the current scenario of the market?
- What leading factors would propel and impede the industry across the geography?
- How has the industry been evolving in terms of geography & Africa HIV Drugs Market adoption?
- How has the competition been shaping up across the geography?
- Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Call + +1 628 895 8081, +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Leave a Reply